Baby Safety / Compounds / Mannitol (E421)

Is Mannitol (E421) safe for babies and kids?

Moderate risk for kids

Infants are more vulnerable to Mannitol (E421) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What is mannitol (e421)?

The IUPAC name is (2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol.

Also known as: (2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol, D-mannitol, mannitol, Mannite.

IUPAC name
(2R,3R,4R,5R)-hexane-1,2,3,4,5,6-hexol
CAS number
69-65-8
Molecular formula
C6H14O6
Molecular weight
182.17 g/mol
SMILES
C(C(C(C(C(CO)O)O)O)O)O
PubChem CID
6251

Risk for babies

Moderate risk

Infants are more vulnerable to Mannitol (E421) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.

What to do: Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Risk for pregnant and nursing people

Context-dependent

Pregnancy alters the metabolism and distribution of Mannitol (E421), potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.

No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.

What to do: Minimize exposure during pregnancy and lactation. Consult healthcare provider regarding specific risks. Consider alternative products with lower hazard profiles.

Regulatory consensus

3 regulatory and scientific bodies have classified Mannitol (E421). The classifications differ — that's the data.

AgencyYearClassificationNotes
US FDA / EFSA (Mannitol — D-mannitol — E421 — FDA GRAS (21 CFR 184.1459 — affirmed GRAS as direct food additive; sweetener, anticaking agent, texturizer); FDA-approved OTC laxative active ingredient; FDA-approved pharmaceutical active ingredient: IV osmotic diuretic (20% mannitol injection — treatment of cerebral edema, acute renal failure, and reduction of intraocular pressure; Aridol — inhaled dry powder mannitol for bronchial provocation testing; Bronchitol — inhaled mannitol for cystic fibrosis treatment); FDA-approved pharmaceutical excipient (inactive ingredient database; oral, parenteral routes); EFSA E421 re-evaluation 2019 — ADI 'not specified'; JECFA ADI 'not specified'; naturally occurring polyol in many plants and fungi (manna ash tree sap — Fraxinus ornus; seaweed; mushrooms); approximately 60% sweetness of sucrose; caloric value approximately 1.6 kcal/g; poorly absorbed from small intestine; osmotic laxative effect; no carcinogenicity classification by IARC, NTP, US EPA, or EFSA)2020no carcinogenicity classification; FDA GRAS 21 CFR 184.1459; FDA-approved IV osmotic diuretic and inhaled CF treatment (Bronchitol); EFSA E421 ADI not specified; osmotic laxative; ~1.6 kcal/g; not classified by IARC, NTP, or EPA for carcinogenicity
EPA CTX / Genetox—Genotoxicity: positive (Ames: positive, 9 positive / 4 negative reports)
EPA CTX / Genetox—Genotoxicity: positive (Ames: positive, 9 positive / 4 negative reports)

Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.

Where kids encounter mannitol (e421)

  • Industrial Facilities — Manufacturing plants, Chemical storage areas, Waste treatment sites
  • Occupational Environments — Factories, Warehouses, Transportation vehicles
  • Consumer Products — dietary supplements, fortified foods, energy drinks

Safer alternatives

Lower-risk approaches that achieve a similar outcome to Mannitol (E421):

  • Fragrance-free formulations
    Trade-offs: Consumer preference for scented products
    Relative cost: Lower (ingredient elimination)
  • Essential oil-based fragrances (with disclosure)
    Trade-offs: Natural does not mean safe — many essential oils are skin sensitizers
    Relative cost: 2-5× conventional

Frequently asked questions

Is mannitol (e421) safe for kids?

Infants are more vulnerable to Mannitol (E421) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.

What products contain mannitol (e421)?

Mannitol (E421) appears in: Manufacturing plants (Industrial facilities); Chemical storage areas (Industrial facilities); Factories (Occupational environments); Warehouses (Occupational environments); dietary supplements (Consumer products).

What should I do if my child is exposed to mannitol (e421)?

Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.

Why do regulators disagree about mannitol (e421)?

Mannitol (E421) has been classified by 3 agencies including US FDA / EFSA (Mannitol — D-mannitol — E421 — FDA GRAS (21 CFR 184.1459 — affirmed GRAS as direct food additive; sweetener, anticaking agent, texturizer); FDA-approved OTC laxative active ingredient; FDA-approved pharmaceutical active ingredient: IV osmotic diuretic (20% mannitol injection — treatment of cerebral edema, acute renal failure, and reduction of intraocular pressure; Aridol — inhaled dry powder mannitol for bronchial provocation testing; Bronchitol — inhaled mannitol for cystic fibrosis treatment); FDA-approved pharmaceutical excipient (inactive ingredient database; oral, parenteral routes); EFSA E421 re-evaluation 2019 — ADI 'not specified'; JECFA ADI 'not specified'; naturally occurring polyol in many plants and fungi (manna ash tree sap — Fraxinus ornus; seaweed; mushrooms); approximately 60% sweetness of sucrose; caloric value approximately 1.6 kcal/g; poorly absorbed from small intestine; osmotic laxative effect; no carcinogenicity classification by IARC, NTP, US EPA, or EFSA), EPA CTX / Genetox, EPA CTX / Genetox, with differing conclusions. Regulators apply different standards of evidence (animal data weighting, exposure-pattern assumptions, epidemiological power thresholds), which is why two scientific bodies can review the same data and reach different conclusions. See the regulatory consensus table on this page for the full picture.

See Mannitol (E421) in the baby app

Look up products containing mannitol (e421), compare to alternatives, and explore the full data record.

Open in baby View raw API data

Sources (1)
  1. FDA GRAS 21 CFR 184.1459 Mannitol Food Additive; EFSA E421 Re-evaluation 2019 ADI Not Specified; FDA IV Osmotic Diuretic 20% Mannitol Injection Cerebral Edema TBI IOP; FDA Bronchitol Inhaled Mannitol Cystic Fibrosis; Aridol Bronchial Provocation; Osmotic Laxative; Not HFI Contraindicated; No IARC NTP EPA EFSA Carcinogenicity Classification (2020) — regulatory

Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →